Q1 2020 Holdings
Filed 2020-05-15 | 110 holdings | $4.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Adaptive Biotechnologies Corporation(ADPT) | COM | 00650F109 | $20.7M | 743,734 | 0.4% |
| BioCryst Pharmaceuticals, Inc.(BCRX) | COM | 09058V103 | $21.9M | 10,946,166 | 0.5% |
| Aurinia Pharmaceuticals Inc.(AUPH) | COM | 05156V102 | $24.7M | 1,701,929 | 0.5% |
| Axsome Therapeutics, Inc.(AXSM) | COM | 05464T104 | $52.3M | 889,757 | 1.1% |
| Cerus Corporation(CERS) | COM | 157085101 | $63.8M | 13,713,195 | 1.4% |
| argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $134.3M | 1,019,557 | 2.9% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $381.8M | 3,390,270 | 8.3% |
| BioMarin Pharmaceutical Inc.(BMRN) | COM | 09061G101 | $641.3M | 7,589,294 | 13.9% |
| BeiGene, Ltd.(ONC) | SPONSORED ADR | 07725L102 | $1.4B | 11,777,285 | 31.5% |
| Acadia Pharmaceuticals Inc.(ACAD) | COM | 004225108 | $1.8B | 41,904,586 | 38.5% |